Colorectal cancer

Improving Survival in Metastatic Colorectal Cancer Through Optimized Patient Selection

Abstract: The systemic treatment options for patients with metastatic colorectal cancer have recently expanded with the US Food and Drug Administration approval of fruquintinib being added to […]

Improving Outcomes in Pediatric NTRK Gene Fusion-Positive Solid Tumors: Importance of Genomic Testing and Targeted Therapy With the TRK Inhibitor Larotrectinib

In the Clinic: Case Studies Let us begin our discussion with 2 pediatric cases that prompt the question, “How will you proceed?” Patient 1: A baby […]